Sample | Title | Value | Rank |
GSM451635 | M15 - infected MBT/Pas fibroblasts (9 h post inf) | 103.2 | 71 |
GSM451636 | M16 - infected MBT/Pas fibroblasts (9 h post inf) | 80.9 | 69 |
GSM451637 | M17 - infected MBT/Pas fibroblasts (9 h post inf) | 114.4 | 73 |
GSM451632 | M11 - non-infected MBT/Pas fibroblasts | 54.9 | 61 |
GSM451633 | M12 - non-infected MBT/Pas fibroblasts | 54.8 | 61 |
GSM451634 | M13 - non-infected MBT/Pas fibroblasts | 66 | 64 |
GSM451629 | B15 - infected BALB/cByJ fibroblasts (9 h post inf) | 23.6 | 42 |
GSM451630 | B16 - infected BALB/cByJ fibroblasts (9 h post inf) | 49.3 | 57 |
GSM451631 | B17 - infected BALB/cByJ fibroblasts (9 h post inf) | 42.1 | 55 |
GSM451626 | B11 - non-infected BALB/cByJ fibroblasts | 29.8 | 48 |
GSM451627 | B12 - non-infected BALB/cByJ fibroblasts | 30 | 47 |
GSM451628 | B13 - non-infected BALB/cByJ fibroblasts | 16.8 | 35 |